Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation-Reference-Cited by-同舟云学术

Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation

Published:2018-05-17 Issue: Volume: Page:
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Liu Tiantian¹,Wang Zhiqiang¹,Chen Xiaoping¹,You Hongjie¹,Xue Jingyi¹,Cai Dayong²,Zheng Yuanyuan¹,Xu Yang¹,Luo Dali¹

Affiliation:

1. Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance; Capital Medical University; Beijing China

2. Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences; Beijing China

Funder

Beijing Innovation Promoting Project

National Natural Science Foundation

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12667/fullpdf

Reference55 articles.

1. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus;Mukherjee;Best Prac Res Clin Endocrinol Metab,2009